97 related articles for article (PubMed ID: 10925882)
1. [The role of capsule formation in Burkholderia mallei for its persistence in vivo].
Popov SF; Tikhonov NG; Piven' NN; Kurilov VIa; Dement'ev IP
Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):73-5. PubMed ID: 10925882
[TBL] [Abstract][Full Text] [Related]
2. [Pseudomonas pseudomallei and Pseudomonas mallei--capsule-forming bacteria].
Popov SF; Kurilov VIa; Iakovlev AT
Zh Mikrobiol Epidemiol Immunobiol; 1995; (5):32-6. PubMed ID: 8525729
[TBL] [Abstract][Full Text] [Related]
3. [Ultrastructural immunochemical study of pathogenic Burkholderia capsule].
Piven' NN; Alekseev VV; Popov SF; Khrapova NP; Prokhvatilova EV; Viktorov DV; Plekhanova NG; Kapliev VI; Avrorova IV
Zh Mikrobiol Epidemiol Immunobiol; 2005; (5):19-24. PubMed ID: 16279528
[TBL] [Abstract][Full Text] [Related]
4. [The parasitism characteristics of the causative agent of melioidosis in the host cells].
Popov SF; Kurilov VIa; Mel'nikov BI
Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):12-4. PubMed ID: 1724859
[TBL] [Abstract][Full Text] [Related]
5. Use of the common marmoset to study Burkholderia mallei infection.
Jelesijevic T; Zimmerman SM; Harvey SB; Mead DG; Shaffer TL; Estes DM; Michel F; Quinn FD; Hogan RJ; Lafontaine ER
PLoS One; 2015; 10(4):e0124181. PubMed ID: 25860021
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.
DeShazer D; Waag DM; Fritz DL; Woods DE
Microb Pathog; 2001 May; 30(5):253-69. PubMed ID: 11373120
[TBL] [Abstract][Full Text] [Related]
7. Using real-time PCR to specifically detect Burkholderia mallei.
Ulrich MP; Norwood DA; Christensen DR; Ulrich RL
J Med Microbiol; 2006 May; 55(Pt 5):551-559. PubMed ID: 16585642
[TBL] [Abstract][Full Text] [Related]
8. [Immunobiological properties of Burkholderia pseudomallei and Burkholderia mallei capsular substances].
Popov SF; Tikhonov NG; Piven' NN; Avrorova IV; Viktorov DV; Kurilov VIa
Zh Mikrobiol Epidemiol Immunobiol; 2002; (6):60-4. PubMed ID: 12506631
[TBL] [Abstract][Full Text] [Related]
9. [Burkholderia mallei and Burkholderia pseudomallei. Study of immuno- and pathogenesis of glanders and melioidosis. Heterologous vaccines].
Manzeniuk IN; Galina EA; Dorokhin VV; Kalachev IIa; Borzenkov VN; Svetoch EA
Antibiot Khimioter; 1999; 44(6):21-6. PubMed ID: 10422574
[TBL] [Abstract][Full Text] [Related]
10. Melioidosis in Birds and Burkholderia pseudomallei Dispersal, Australia.
Hampton V; Kaestli M; Mayo M; Choy JL; Harrington G; Richardson L; Benedict S; Noske R; Garnett ST; Godoy D; Spratt BG; Currie BJ
Emerg Infect Dis; 2011 Jul; 17(7):1310-2. PubMed ID: 21762599
[No Abstract] [Full Text] [Related]
11. [The pathomorphology and pathogenesis of glanders in laboratory animals].
Diadishchev NR; Vorob'ev AA; Zakharov SB
Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):60-4. PubMed ID: 9245146
[TBL] [Abstract][Full Text] [Related]
12. Molecular insights into Burkholderia pseudomallei and Burkholderia mallei pathogenesis.
Galyov EE; Brett PJ; DeShazer D
Annu Rev Microbiol; 2010; 64():495-517. PubMed ID: 20528691
[TBL] [Abstract][Full Text] [Related]
13. Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.
Zimmerman SM; Long ME; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
Vet Pathol; 2018 Mar; 55(2):258-267. PubMed ID: 29145795
[TBL] [Abstract][Full Text] [Related]
14. [Capsule formation in the causative agent of glanders].
Popov SF; Mel'nikov BI; Lagutin MP; Kurilov VIa
Mikrobiol Zh (1978); 1991; 53(1):90-2. PubMed ID: 2067426
[TBL] [Abstract][Full Text] [Related]
15. Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.
Bernhards RC; Cote CK; Amemiya K; Waag DM; Klimko CP; Worsham PL; Welkos SL
Arch Microbiol; 2017 Mar; 199(2):277-301. PubMed ID: 27738703
[TBL] [Abstract][Full Text] [Related]
16. A novel selective medium for the isolation of Burkholderia mallei from equine specimens.
Kinoshita Y; Cloutier AK; Rozak DA; Khan MSR; Niwa H; Uchida-Fujii E; Katayama Y; Tuanyok A
BMC Vet Res; 2019 May; 15(1):133. PubMed ID: 31064357
[TBL] [Abstract][Full Text] [Related]
17. Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse.
Lever MS; Nelson M; Ireland PI; Stagg AJ; Beedham RJ; Hall GA; Knight G; Titball RW
J Med Microbiol; 2003 Dec; 52(Pt 12):1109-1115. PubMed ID: 14614070
[TBL] [Abstract][Full Text] [Related]
18. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection.
Zimmerman SM; Michel F; Hogan RJ; Lafontaine ER
PLoS One; 2015; 10(5):e0126437. PubMed ID: 25993100
[TBL] [Abstract][Full Text] [Related]
19. The hamster model of intraperitoneal Burkholderia mallei (glanders).
Fritz DL; Vogel P; Brown DR; Waag DM
Vet Pathol; 1999 Jul; 36(4):276-91. PubMed ID: 10421094
[TBL] [Abstract][Full Text] [Related]
20. Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei).
Fritz DL; Vogel P; Brown DR; Deshazer D; Waag DM
Vet Pathol; 2000 Nov; 37(6):626-36. PubMed ID: 11105952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]